Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Milestone (MMD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.58 0.00    0.00%
18/12 - Closed. Currency in PLN ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 1.50 / 1.58
  • Day's Range: 1.50 - 1.58
Type:  Equity
Market:  Poland
ISIN:  USU6005B1045 
Milestone 1.58 0.00 0.00%

Milestone Company Profile

 
Read the Milestone company profile to learn more about the business and the management team. View Milestone facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

14

Equity Type

ORD

Milestone Medical, Inc. develops, manufactures, commercializes, and markets intra-articular and epidural drug delivery systems in the United States and Europe. The company’s products are based on computer-controlled injection and drug delivery technology. Its products include dynamic pressure sensing system, a patented computer-controlled injection system that measures the density of body tissue and helps clinician know the location of a hypodermic needle during an injection; and intra-articular injection instrument that is used to inject into various joints in treatment of arthritis and other joint conditions. The company was formerly known as Milestone Scientific Research and Development, Inc. Milestone Medical, Inc. The company was incorporated in 2011 and is based in Roseland, New Jersey. Milestone Medical, Inc. is a subsidiary of Milestone Scientific, Inc.

Contact Information

Address 425 Eagle Rock Avenue Suite 403
Roseland, 07068
United States
Phone 973 535 2717
Fax 973 535 2829

Top Executives

Name Age Since Title
Edward J. Zelnick 77 - Director of Clinical Research & Member of Scientific Advisory Board
Lorrence Howell Green - - Member of Scientific Advisory Board
Jan Adriaan Haverhals 61 2021 CEO & Director
Ralf Erich Gebhard - - Member of Scientific Advisory Board
Mark Hochman 65 2011 Clinical Director, Director of Research & Development and Member of Scientific Advisory Board
Paul J. Davis - - Member of Scientific Advisory Board
Benedetta I. Casamento 56 2023 Director
Neal Ira Goldman 79 2023 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MMD Price Commentary

Write your thoughts about Milestone
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email